Published in Clinical Trials Week, November 29th, 2004
The company reported total revenue of $28.5 million for the 3 months ended September 30, 2004, compared to $27.4 million for the third quarter of 2003. In the third quarter of 2004, product sales were $5.0 million compared to $7.7 million in 2003, and contract revenue totaled $23.6 million compared to $19.6 million in the third quarter of 2003.
The company reported a net loss of $20.5 million or $(0.24) per share for the 3 months ended September 30, 2004, compared to a net loss of $17.2 million or $(0.31) per share for the 3 months ended...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.